menu search

Krystal biotech: 2 potential regulatory approvals to carry it forward

Krystal Biotech, Inc. has a PDUFA date of May 19, 2023, established for the FDA to review B-VEC for potential U.S. marketing approval to treat patient...

May 8, 2023, 2:27 pm

Biora therapeutics to report first quarter 2023 financial results and provide corporate update

SAN DIEGO, May 08, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech compa...

May 8, 2023, 1:00 pm

Krystal biotech announces first quarter 2023 financial results and operational highlights

PDUFA date of May 19, 2023 Presented clinical data at ARVO on topical application of B-VEC to the eye to treat ocular complications in a patient with ...

May 8, 2023, 12:23 pm

Immunogen nearly triples on ovarian cancer drug phase 3 results

Commercial-state biotechnology company ImmunoGen Inc. NASDAQ: IMGN shares more than doubled on phase 3 clinical trial results. Its ovarian cancer drug...

May 8, 2023, 8:31 am

Benitec biopharma to present at the opmd international conference

HAYWARD, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a development-stage, gene th...

May 8, 2023, 8:05 am

Relmada therapeutics to report first quarter 2023 financial results and host conference call and webcast on may 11, 2023

CORAL GABLES, Fla. , May 8, 2023 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of ...

May 8, 2023, 7:30 am

Biontech's stock jumps 4.3% premarket after earnings fall but top estimates

BioNTEch SE's stock BNTX rose 4.3% in premarket trade Monday, after the German biotech posted far stron...

May 8, 2023, 7:09 am

Araris biotech supported with chf 2.5m swiss accelerator grant from innosuisse to develop antibody-drug conjugate candidates

The Swiss Accelerator programme’s total funding grant amounted to CHF 112M (~$125 million) with support per project amounting to a maximum of CHF 2....

May 8, 2023, 4:44 am

2 best biotech stocks to buy right now

Eli Lilly and Amgen both boast exceptional product portfolios and pipelines. The two companies pay growing dividends to shareholders....

May 6, 2023, 7:55 am

Puma biotech (pbyi) q1 earnings beat, nerlynx sales rise y/y

Puma Biotechnology (PBYI) earnings and sales beat estimates in Q1. Stock rises in after-hours....

May 5, 2023, 2:27 pm

Nanobiotix stock skyrockets on final negotiations with ‘major' drug maker for its cancer treatment

Nanobiotix SA (EPA:NANO) shares soared 250% to $7.11, on volume of more than 29 million shares, Friday after the France-based clinical biotechnology c...

May 5, 2023, 12:56 pm

Nanobiotix stock more than triples, after biotech enters final negotiations with ‘major' drug maker on development of cancer treatment

The U.S.-listed shares of Nanobiotix S.A. NBTX blasted 221.7% higher on massive volume Friday, to pace all gainers trading on major U.S. exchanges, af...

May 5, 2023, 12:08 pm

Protagonist, a top 1% biotech, briefly breaks out on psoriasis enthusiasm

Shares of PTGX stock briefly broke out Friday after Protagonist said it plans to soon present new test results for its psoriasis drug. The post Protag...

May 5, 2023, 11:58 am

Top-notch biotech apellis soars after new drug obliterates sales views

Apellis' new eye drug, Syfovre, crushed expectations in its first quarter post launch, putting APLS stock on track to open at a record high. The post ...

May 5, 2023, 9:36 am

Araris biotech ag supported with chf 2.5m swiss accelerator grant from innosuisse to develop antibody-drug conjugate candidates

Innosuisse supports 53 companies out of 752 applications with total CHF 112M Araris’ awarded grant will be used to support further development and a...

May 5, 2023, 6:14 am

Puma biotechnology, inc. (pbyi) q1 2023 earnings call transcript

Puma Biotechnology, Inc. (NASDAQ:PBYI ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Mariann Ohanesian - Senior Direct...

May 4, 2023, 10:54 pm

Vir biotechnology, inc. (vir) reports q1 loss, tops revenue estimates

Vir Biotechnology, Inc. (VIR) came out with a quarterly loss of $1.06 per share versus the Zacks Consensus Estimate of a loss of $0.81. This compares ...

May 4, 2023, 9:17 pm

Vyant bio announces filing of form 25 for voluntary nasdaq delisting and sec deregistration

CHERRY HILL, N.J., May 04, 2023 (GLOBE NEWSWIRE) — Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is a biotechnology company that...

May 4, 2023, 8:30 pm

Puma biotech (pbyi) q1 earnings and revenues top estimates

Puma biotech (PBYI) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Es...

May 4, 2023, 7:44 pm

Becton dickinson ceo: q2 ‘was another quarter of exceeding expectations'

Becton, Dickinson and Company CEO and President Tom Polen joins Yahoo Finance Live to discuss company earnings, growth opportunities in the home test ...

May 4, 2023, 3:45 pm


Search within

Pages Search Results: